Correlation Between Kalvista Pharmaceuticals and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kalvista Pharmaceuticals and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kalvista Pharmaceuticals and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kalvista Pharmaceuticals and Mersana Therapeutics, you can compare the effects of market volatilities on Kalvista Pharmaceuticals and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kalvista Pharmaceuticals with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kalvista Pharmaceuticals and Mersana Therapeutics.
Diversification Opportunities for Kalvista Pharmaceuticals and Mersana Therapeutics
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kalvista and Mersana is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and Kalvista Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kalvista Pharmaceuticals are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of Kalvista Pharmaceuticals i.e., Kalvista Pharmaceuticals and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between Kalvista Pharmaceuticals and Mersana Therapeutics
Given the investment horizon of 90 days Kalvista Pharmaceuticals is expected to generate 0.52 times more return on investment than Mersana Therapeutics. However, Kalvista Pharmaceuticals is 1.92 times less risky than Mersana Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Mersana Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 517.00 in Kalvista Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 498.00 from holding Kalvista Pharmaceuticals or generate 96.32% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kalvista Pharmaceuticals vs. Mersana Therapeutics
Performance |
| Timeline |
| Kalvista Pharmaceuticals |
| Mersana Therapeutics |
Kalvista Pharmaceuticals and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kalvista Pharmaceuticals and Mersana Therapeutics
The main advantage of trading using opposite Kalvista Pharmaceuticals and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kalvista Pharmaceuticals position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.| Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |